28 min listen
Peptide Receptor Radionuclide Therapy (PRRT): What Surgeons Need to Know
FromSurgOnc Today®
ratings:
Length:
21 minutes
Released:
Nov 20, 2020
Format:
Podcast episode
Description
In this episode of SurgOnc Today™, Gastrointestinal Disease Site Work Group Chair, Vance Sohn, MD, discusses PRRT with SSO President, James Howe, MD and Thomas Clancy, MD from the Gastrointestinal Disease Site Work Group. They discuss the current indications, efficacy, and what the future holds for PRRT.
Released:
Nov 20, 2020
Format:
Podcast episode
Titles in the series (99)
Practice Changing Studies in Melanoma Surgical Oncology: Tina J. Hieken, MD, Vice Chair of the SSO Melanoma Disease Site Work Group, moderates as Melanoma DSWG members, Jessica Cintolo-Gonzalez, MD, and Kelly Olino, MD, present practice changing studies from 2019. by SurgOnc Today®